株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

英国の臨床化学および免疫診断市場:市場規模予測、サプライヤーシェア、競争戦略

2015 UK Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies

発行 Venture Planning Group 商品コード 278131
出版日 ページ情報 英文 563 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。

Local License: 同一事業所内

Back to Top
英国の臨床化学および免疫診断市場:市場規模予測、サプライヤーシェア、競争戦略 2015 UK Clinical Chemistry and Immunodiagnostic Markets: Supplier Shares, Country Forecasts, Innovative Technologies, Competitive Strategies
出版日: ページ情報: 英文 563 Pages
担当者のコメント
このシリーズは、他にも調査対象国がございます。詳細はお問合せください。
概要

当レポートでは、英国における臨床化学・免疫診断関連市場について分析し、研究開発の最新動向や将来展望、各国の試薬(100種類以上)の売上高の予測値(今後5年間分)、主要サプライヤーの売上高・市場シェア、主な解析装置の機能比較、主要企業のプロファイルなどを調査・推計して、その結果を概略以下の構成でお届けします。

第1章 イントロダクション

第2章 世界の市場・技術の概要

  • 主なルーチン化学検査製品(全30種)
  • 治療薬物モニタリング(TDM)(全17種)
  • 内分泌機能検査(全20種)
  • 腫瘍市場と特殊化学検査(全12種)
  • 免疫タンパク質検査(全7種)
  • 薬物乱用(全12種)
  • 診断装置のレビュー:機能上の特徴、大〜小量/POC解析装置
  • 主な体外診断技術とその潜在的用途
    • モノクローナル・ポリクローナル抗体
    • 免疫学的検定
    • タンデム質量分析
    • ITおよびオートメーション
    • ドライケミストリー
    • バイオセンサー

第3章 英国市場

  • エグゼクティブ・サマリー
  • 事業環境
  • 市場構造
  • 市場規模・成長率、主要サプライヤーの装置・試薬売上高および市場シェア

第4章 主な製品開発機会

第5章 分散型検査製品の設計基準

第6章 代替的な市場参入戦略

  • 内部開発
  • 協働事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

第7章 潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

第8章 競合企業プロファイル

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • 栄研化学
  • 富士レビオ/Innogenetics
  • Instrumentation Laboratory
  • 協和メデックス
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • シスメックス
  • Thermo Fisher
  • 東ソー
  • 和光純薬工業
  • Wallac/PE

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPCC8444

Is a new strategic analysis of major business opportunities emerging in the UK clinical chemistry and immunodiagnostic markets during the next five years.  The report explores future trends in the UK market; provides estimates of the specimen, test and sales volumes, as well as major suppliers’ sales and market shares; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities emerging during the next five years.

The report provides five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in hospitals, commercial laboratories, physician offices, and ambulatory care centers, including controls, calibrators and consumables.

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

A. Major Routine Chemistry Tests

  • 1. Albumin
  • 2. Alkaline Phosphatase
  • 3. ALT/SGPT
  • 4. Ammonia
  • 5. Amylase
  • 6. AST/SGOT
  • 7. Bilirubin, Total
  • 8. Blood Gases
  • 9. Blood Urea Nitrogen (BUN)
  • 10. Calcium
  • 11. Cardio CRP
  • 12. Cholesterol
  • 13. Cholinesterase
  • 14. CRP
  • 15. Creatinine
  • 16. Electrolytes
    • a. Carbon Dioxide/Bicarbonate
    • b. Chloride
    • c. Potassium
    • d. Sodium
  • 17. Ferritin
  • 18. Fructosamine
  • 19. Gamma-Glutamyl Transpeptidase (GGT)
  • 20. Glucose
  • 21. High Density Lipoprotein (HDL)
  • 22. Homocysteine
  • 23. Iron
  • 24. Lactate Dehydrogenase (LDH)
  • 25. Magnesium
  • 26. Phosphorus
  • 27. Protein
  • 28. Triglycerides
  • 29. Uric Acid
  • 30. Troponin

B. Therapeutic Drug Monitoring (TDM)

  • 1. Overview
  • 2. Carbamazepine
  • 3. Cyclosporin
  • 4. Digoxin
  • 5. Everolimus
  • 6. Gentamicin
  • 7. Lamotrigine/Lamictal
  • 8. Levetiracetam
  • 9. Lidocaine
  • 10. Lithium
  • 11. NAPA/Procainamide
  • 12. Phenytoin
  • 13. Quinidine
  • 14. Sirolimus
  • 15. Tacrolimus
  • 16. Theophylline
  • 17. Topirimate
  • 18. Valproic Acid

C. Endocrine Function Tests

  • 1. Cortisol
  • 2. Estradiol
  • 3. Follicle-Stimulating Hormone (FSH)
  • 4. Gastrin
  • 5. Growth Hormone/IGF-1
  • 6. Human Chorionic Gonadotropin (HCG)
  • 7. LH
  • 8. Progesterone
  • 9. PTH/IO PTH
  • 10. Prolactin
  • 11. T3
  • 12. T3 Free
  • 13. T3 Uptake
  • 14. T4 (Thyroxine)
  • 15. T4 Free
  • 16. TBG
  • 17. Testosterone
  • 18. Thyroglobulin Ab
  • 19. TPO Ab
  • 20. TSH

D. Tumor Markers And Special Chemistry Tests

  • 1. AFP
  • 2. CA 15-3
  • 3. CA 19-9
  • 4. CA 27-29
  • 5. Carcinoembrionic Antigen (CEA)
  • 6. Folate/Folic Acid
  • 7. HCG
  • 8. 25-Hydroxy Vitamin D2 and D3
  • 9. Occult Blood
  • 10. Prostate-Specific Antigen (PSA)
  • 11. Thyroglobulin
  • 12. Vitamin B-12

E. Immunoprotein Tests

  • 1. Complement
    • a. C3
    • b. C4
  • 2. Free Light Chains
  • 3. Immunofixation
  • 4. Immunoglobulins (IgA, IgE, IgG, IgM)
  • 5. Haptoglobin
  • 6. Prealbumin
  • 7. Protein Electrophoresis

F. Drugs of Abuse

  • 1. Overview
  • 2. Test Methodologies
  • 3. Amphetamines
  • 4. Barbiturates
  • 5. Benzodiazepines
  • 6. Cannabinoids/Marijuana
  • 7. Cocaine
  • 8. Lysergic Acid Diethylamide (LSD)
  • 9. Methadone
  • 10. Methaqualone
  • 11. Opiates
  • 12. Phencyclidine
  • 13. Tricyclic Antidepressants

G. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers

H. Major In Vitro Diagnostic Technologies And Their Potential Applications

  • 1. Monoclonal and Polyclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Chemiluminescence
    • c. Enzyme Immunoassays (EIA)
      • Overview
      • ELISA
      • EMIT
      • Electrochemical
    • d. Radioimmunoassays (RIA)
    • e. Immunoprecipitation
    • f. Affinity Chromatography
  • 3. Tandem Mass Spec
  • 4. IT and Automation
  • 5. Dry Chemistry
  • 6. Biosensors

III. UK

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Growth and Major Suppliers' Instrument and Reagent Sales and Market Shares

X. Major Product Development Opportunities

XI. Design Criteria for Decentralized Testing Products

XII. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

XIII. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

XIV. Competitive Assessments

  • Abbott Laboratories
  • AdnaGen
  • Agilent Technologies
  • Beckman Coulter/Danaher
  • Biomedical Diagnostics
  • BioMerieux
  • Bio-Rad
  • DiaSorin
  • Eiken
  • Fujirebio/Innogenetics
  • Instrumentation Laboratory
  • Kyowa Medex
  • Matritech/Alere
  • Ortho-Clinical Diagnostics
  • Quest Diagnostics
  • Roche
  • Siemens
  • Sysmex
  • Thermo Fisher
  • Tosoh
  • Wako
  • Wallac/PE

List of Tables

  • Major Companies Developing or Marketing Albumin Tests
  • Major Companies Developing or Marketing Alkaline Phosphatase Tests
  • Major Companies Developing or Marketing ALT/SGPT Tests
  • Major Companies Developing or Marketing Amylase Tests
  • Major Companies Developing or Marketing AST/SGOT Tests
  • Major Companies Developing or Marketing Bilirubin Tests
  • Major Companies Developing or Marketing Blood Gas Analyzers
  • Major Companies Developing or Marketing BUN Tests
  • Major Companies Developing or Marketing Calcium Tests
  • Major Companies Developing or Marketing Cholesterol Tests
  • Major Companies Developing or Marketing Creatinine Tests
  • Major Companies Developing or Marketing Electrolyte Tests
  • Major Companies Developing or Marketing GGT Tests
  • Major Companies Developing or Marketing Glucose Tests
  • Major Companies Developing or Marketing HDL Tests
  • Major Companies Developing or Marketing Iron Tests
  • Major Companies Developing or Marketing LDH Tests
  • Major Companies Developing or Marketing Magnesium Tests
  • Major Companies Developing or Marketing Phosphorus Tests
  • Major Companies Developing or Marketing Protein Tests
  • Major Companies Developing or Marketing Triglycerides Tests
  • Major Companies Developing or Marketing Uric Acid Tests
  • Major Companies Developing or Marketing TDM Tests
  • Major Companies Developing or Marketing Digoxin Tests
  • Major Companies Developing or Marketing Lithium Tests
  • Major Companies Developing or Marketing Phenytoin/Dilantin Tests
  • Major Companies Developing or Marketing Theophylline Tests
  • Major Companies Developing or Marketing Valproic Acid Tests
  • Major Companies Developing or Marketing FSH Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing LH Tests
  • Major Companies Developing or Marketing Prolactin Tests
  • Major Companies Developing or Marketing T3 Tests
  • Major Companies Developing or Marketing T4 Tests
  • Major Companies Developing or Marketing TSH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing Prostatic Acid Phosphatase Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Vitamin B-12/Folate Tests
  • Major Companies Developing or Marketing CRP Tests
  • Major Companies Developing or Marketing Drugs of Abuse Tests
  • Major Companies Developing or Marketing Biosensors for Immunological Testing
  • Executive Summary Table: U.K., Clinical Chemistry and Immunoassay Test Volume And Diagnostics Sales Forecast By Test Category
  • U.K., Laboratories Performing Chemistry and Immunoassay Testing By Market Segment
  • U.K., Hospital Laboratories Performing Chemistry and Immunoassay Tests By Bed Size
  • U.K., Commercial/Private Laboratories Performing Chemistry and Immunoassay Tests By Annual Test Volume
  • U.K., Total Chemistry and Immunoassay Specimen Volume Forecast
  • U.K., All Market Segments, Specimen Volume Forecast By Test Category
  • U.K., Total Clinical Chemistry and Immunoassay Test Volume Forecast By Test Category
  • U.K., Routine Chemistry Test Volume Forecast By Market Segment
  • U.K., Endocrine Function Test Volume Forecast By Market Segment
  • U.K., Tumor Markers and Special Chemistry Test Volume Forecast By Market Segment
  • U.K., Immunoprotein Test Volume Forecast By Market Segment
  • U.K., TDM Test Volume Forecast By Market Segment
  • U.K., Drugs of Abuse Test Volume Forecast By Market Segment
  • U.K., All Market Segments, Profiles, Panels and Individual Tests Forecast
  • U.K., Hospital Laboratories, Profiles, Panels and Individual Tests Forecast
  • U.K., Commercial/Private Laboratories, Profiles, Panels and Individual Tests Forecast
  • U.K., All Market Segments, Routine Chemistry Test Volume Forecast by Assay
  • U.K., Hospital Laboratories, Routine Chemistry Test Volume Forecast by Assay
  • U.K., Commercial/Private Laboratories, Routine Chemistry Test Volume Forecast by Assay
  • U.K., All Market Segments, Endocrine Function Test Volume Forecast by Assay
  • U.K., Hospital Laboratories, Endocrine Function Test Volume Forecast by Assay
  • U.K., Commercial/Private Laboratories, Endocrine Function Test Volume Forecast by Assay
  • U.K., All Market Segments, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.K., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Test Volume Forecast by Assay
  • U.K., All Market Segments, Immunoprotein Test Volume Forecast by Assay
  • U.K., Hospital Laboratories, Immunoprotein Test Volume Forecast by Assay
  • U.K., Commercial/Private Laboratories, Immunoprotein Test Volume Forecast by Assay
  • U.K., All Market Segments, TDM Test Volume Forecast by Assay by Assay
  • U.K., Hospital Laboratories, TDM Test Volume Forecast by Assay
  • U.K., Commercial/Private Laboratories, TDM Test Volume Forecast by Assay
  • U.K., All Market Segments, Drugs of Abuse Test Volume Forecast by Assay
  • U.K., Hospital Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • U.K., Commercial/Private Laboratories, Drugs of Abuse Test Volume Forecast by Assay
  • U.K., Total Clinical Chemistry and Immunoassay Reagent Market Forecast By Test Category
  • U.K., Clinical Chemistry and Immunoassay Calibrator and Control Market Forecast By Test Category
  • U.K., Routine Chemistry Reagent Market Forecast By Market Segment
  • U.K., Endocrine Function Reagent Market Forecast By Market Segment
  • U.K., Tumor Markers and Special Chemistry Reagent Market Forecast By Market Segment
  • U.K., Immunoprotein Reagent Market Forecast By Market Segment
  • U.K., TDM Reagent Market Forecast By Market Segment
  • U.K., Drugs of Abuse Reagent Market Forecast By Market Segment
  • U.K., All Market Segments, Routine Chemistry Reagent Market Forecast by Assay
  • U.K., Hospital Laboratories, Routine Chemistry Reagent Market Forecast by Assay
  • U.K., Commercial/Private Laboratories, Routine Chemistry Reagent Market Forecast by Assay
  • U.K., All Market Segments, Endocrine Function Reagent Market Forecast by Assay
  • U.K., Hospital Laboratories, Endocrine Function Reagent Market Forecast by Assay
  • U.K., Commercial/Private Laboratories, Endocrine Function Reagent Market Forecast by Assay
  • U.K., All Market Segments, Immunoprotein Reagent Market Forecast by Assay
  • U.K., Hospital Laboratories, Immunoprotein Reagent Market Forecast by Assay
  • U.K., Commercial/Private Laboratories, Immunoprotein Reagent Market Forecast by Assay
  • U.K., All Market Segments, TDM Reagent Market Forecast by Assay
  • U.K., Hospital Laboratories, TDM Reagent Market Forecast by Assay
  • U.K., Commercial/Private Laboratories, TDM Reagent Market Forecast by Assay
  • U.K., All Market Segments, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.K., Hospital Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.K., Commercial/Private Laboratories, Tumor Markers and Special Chemistry Reagent Market Forecast by Assay
  • U.K., All Market Segments, Drugs of Abuse Reagent Market Forecast by Assay
  • U.K., Hospital Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • U.K., Commercial/Private Laboratories, Drugs of Abuse Reagent Market Forecast by Assay
  • U.K., Clinical Chemistry and Immunoassay Instrument Market Forecast By Analyzer Type
  • U.K., Major Suppliers of Clinical Chemistry Diagnostic Products, Estimated Sales and Market Shares
  • U.K., Major Suppliers of Immunoassay Diagnostic Products, Estimated Sales and Market Shares
Back to Top